Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF + Ganciclovir for CMV Retinitis in AIDS
NCT00000989Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in cytomegalovirus retinitis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
sargramostim
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00000989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000989.